NEXT Life Sciences Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 21

NEXT Life Sciences General Information

Description

Developer of a reproductive health biotechnology platform designed to provide non-hormonal male contraception. The company offers hydrogel polymer filtration, vas deferens occlusion, non-hormonal sperm blocking, reversible gel dissolution, precision delivery feedback, and clinical trial management, enabling adult men to access a long-term contraceptive method that does not require daily adherence or hormonal changes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1241 Johnson Avenue
  • Suite 343
  • San Luis Obispo, CA 93401
  • United States
+1 (209)
Primary Industry
Other Devices and Supplies
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 1241 Johnson Avenue
  • Suite 343
  • San Luis Obispo, CA 93401
  • United States
+1 (209)

NEXT Life Sciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NEXT Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 12-Nov-2026 Completed Clinical Trials - Phase 4
5. Later Stage VC (Series B) 14-Oct-2025 Cancelled Clinical Trials - Phase 4
4. Early Stage VC (Series A) 31-Dec-2025 Completed Clinical Trials - Phase 4
3. Grant 30-Jan-2025 Completed Clinical Trials - Phase 4
2. Seed Round 30-Jun-2024 $4M $4M Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view NEXT Life Sciences’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

NEXT Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a reproductive health biotechnology platform designed to provide non-hormonal male contraception. The compa
Other Devices and Supplies
San Luis Obispo, CA
22 As of 2026

Charlottesville, VA
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NEXT Life Sciences Competitors (2)

One of NEXT Life Sciences’s 2 competitors is Contraline, a Venture Capital-Backed company based in Charlottesville, VA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Contraline Venture Capital-Backed Charlottesville, VA
YourChoice Therapeutics Venture Capital-Backed San Francisco, CA
You’re viewing 2 of 2 competitors. Get the full list »

NEXT Life Sciences Patents

NEXT Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024366653-A1 Apparatus and method for delivery and/or removal of occlusions in the body Pending 27-Oct-2023
EP-4568623-A2 Apparatus and method for delivery and/or removal of occlusions in the body Pending 27-Oct-2023
US-12370078-B2 Apparatus and method for delivery and/or removal of occlusions in the body Active 27-Oct-2023
US-20250134701-A1 Apparatus and method for delivery and/or removal of occlusions in the body Active 27-Oct-2023
US-20250143917-A1 Apparatus and method for delivery and/or removal of occlusions in the body Pending 27-Oct-2023 A61F6/225
To view NEXT Life Sciences’s complete patent history, request access »

NEXT Life Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NEXT Life Sciences Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eir Women's Health Accelerator Accelerator/Incubator
Break Trail Ventures Venture Capital Minority
Everybody Ventures Venture Capital Minority
Male Contraception Initiative (MCI) Corporation
Angel (individual) Minority
You’re viewing 5 of 21 investors. Get the full list »

NEXT Life Sciences FAQs

  • When was NEXT Life Sciences founded?

    NEXT Life Sciences was founded in 2022.

  • Where is NEXT Life Sciences headquartered?

    NEXT Life Sciences is headquartered in San Luis Obispo, CA.

  • What is the size of NEXT Life Sciences?

    NEXT Life Sciences has 22 total employees.

  • What industry is NEXT Life Sciences in?

    NEXT Life Sciences’s primary industry is Other Devices and Supplies.

  • Is NEXT Life Sciences a private or public company?

    NEXT Life Sciences is a Private company.

  • What is NEXT Life Sciences’s current revenue?

    The current revenue for NEXT Life Sciences is .

  • How much funding has NEXT Life Sciences raised over time?

    NEXT Life Sciences has raised $24M.

  • Who are NEXT Life Sciences’s investors?

    Eir Women's Health Accelerator, Break Trail Ventures, Everybody Ventures, Male Contraception Initiative (MCI), and are 5 of 21 investors who have invested in NEXT Life Sciences.

  • Who are NEXT Life Sciences’s competitors?

    Contraline and YourChoice Therapeutics are competitors of NEXT Life Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process